Europe Digital Therapeutics Market expected to grow at a CAGR of 21.4% during 2024-2031 | Major Companies 2026 - Pear Therapeutics, Akili Interactive Labs, Click Therapeutics

Leander, Texas and Tokyo, Japan - Jan.06.2026
As per DataM intelligence research report" The Europe Digital Therapeutics Market is expected to grow at a CAGR of 21.4% during the forecast period 2024-2031." Personalized digital interventions and chronic disease management are boosting Europe's digital therapeutics market.

Download your exclusive sample report today: (corporate email gets priority access):
https://www.datamintelligence.com/download-sample/europe-digital-therapeutics-market?prasad

Europe: Recent Industry Developments

✅ In November 2025, Sidekick Health (Iceland/Europe) partnered with a major pharma firm for an oncology DTx The app manages symptoms and side effects for patients undergoing chemotherapy It integrates digital support into the standard of care for cancer in Europe

✅ In October 2025, DiGA (Germany) added a new depression app to its reimbursement list The prescription app offers immediate access to CBT while patients wait for therapy It continues Germany's leadership in reimbursing digital health apps

✅ In September 2025, HelloBetter launched a stress management DTx for the Swiss market The program is reimbursed by Swiss insurers to prevent burnout in the workforce It addresses the mental health crisis in the European corporate sector

✅ In August 2025, The UK NICE issued guidance recommending a DTx for insomnia as a first-line treatment The guidance prioritizes the app over sleeping pills for chronic sleep issues It shifts the NHS prescribing habits toward digital interventions

United States: Recent Industry Developments

✅ In November 2025, Pear Therapeutics (re-emerged) received FDA clearance for a schizophrenia DTx The app helps patients manage auditory hallucinations through cognitive training It offers a non-drug tool for a severe mental illness

✅ In October 2025, Akili Interactive released an adult version of its ADHD video game treatment The game targets attention deficits in the adult workforce It expands the market for "prescription video games" in the U.S.

✅ In September 2025, DarioHealth acquired a musculoskeletal DTx company The acquisition bundles physical therapy with metabolic coaching It creates a comprehensive chronic care platform for U.S. payers

✅ In August 2025, A U.S. insurance giant launched a "Digital Formulary" for its members The formulary creates a tiered copay system for validated health apps It normalizes the payment model for digital medicine

Europe Digital Therapeutics Market: Drivers
The Europe digital therapeutics market is growing due to rising adoption of software-based interventions for chronic disease management and behavioral health. Increasing prevalence of diabetes, obesity, and mental health disorders drives demand. Integration with mobile apps, telehealth, and wearable devices enhances treatment efficacy. Regulatory support and reimbursement frameworks encourage adoption. Expansion of healthcare IT infrastructure strengthens market penetration. Research and development in personalized and evidence-based digital therapies accelerates innovation.

Market growth is reinforced by increasing patient awareness and acceptance of digital interventions. Healthcare providers are integrating digital therapeutics into standard care. Collaborations between software developers and clinical institutions improve treatment outcomes. Emerging European markets show increasing investment in health technology. Integration with EHR and data analytics enhances patient monitoring. Digital therapeutics is becoming an essential component of modern healthcare delivery in Europe.

Get Customization in the report as per your requirements: https://www.datamintelligence.com/customize/europe-digital-therapeutics-market?prasad

Europe Digital Therapeutics Market: Major Players
Pear Therapeutics, Akili Interactive Labs, Click Therapeutics, WellDoc, Livongo (now part of Teladoc Health), Omada Health, Propeller Health (acquired by ResMed), Hinge Health, 2Morrow Inc., DarioHealth, Voluntis, Science 37, Cognoa, NightWare and Kaia Health.

Segment Covered in the Europe Digital Therapeutics Market:
By Product Type
The market is segmented into software 65%, devices 25%, and others 10%, with software dominating due to scalable solutions, ease of integration with healthcare systems, and growing adoption for chronic disease management. Devices are growing with wearable integration and remote monitoring capabilities. Other products, including supporting tools and platforms, are gradually increasing with digital health innovation. Increasing healthcare digitization and regulatory support drive market growth.

By Application
Applications include diabetes 25%, obesity 20%, cardiovascular diseases (CVD) 15%, central nervous system (CNS) diseases 10%, respiratory diseases 8%, smoking cessation 7%, gastrointestinal disorders (GID) 5%, and others 10%, with diabetes and obesity leading due to high prevalence and demand for lifestyle and chronic disease management solutions. CVD and CNS diseases are growing with personalized therapy adoption. Digital therapeutics for respiratory and GID conditions are emerging. Rising chronic disease burden and preventive healthcare awareness support market expansion.

By Sales Channel
Sales channels include business-to-business (B2B) 60% and business-to-consumer (B2C) 40%, with B2B dominating due to partnerships with healthcare providers, employers, payers, and pharmaceutical companies. B2C is growing with direct patient and caregiver engagement through apps and platforms. Healthcare digitization, telemedicine adoption, and increasing patient awareness drive channel growth.

Regional Analysis - By Country
Germany - 25% Share
Germany leads with 25% share due to strong digital health infrastructure, high adoption of digital therapeutics, and supportive government policies. Diabetes and obesity management dominate applications. Software solutions are widely adopted, with B2B channels preferred. Increasing awareness and reimbursement initiatives drive growth.

United Kingdom - 20% Share
The UK holds 20% share with growing adoption of digital therapeutics for chronic disease management and mental health. Diabetes, CVD, and obesity are key applications. Software solutions dominate, with B2B partnerships leading sales. Telehealth and digital health initiatives accelerate adoption.

France - 15% Share
France accounts for 15% share due to rising chronic disease prevalence and digital health programs. Diabetes and CNS diseases are primary applications. Software adoption is strong, supported by B2B healthcare provider partnerships. Government-backed digital health strategies support growth.

Italy - 15% Share
Italy holds 15% share with increasing interest in obesity and diabetes management solutions. B2B adoption with healthcare providers and payers dominates. Digital therapeutics software leads the product segment. Awareness campaigns and healthcare digitalization initiatives drive market adoption.

Spain - 10% Share
Spain records 10% share with growing adoption of digital therapeutics in diabetes and respiratory disease management. Software solutions are leading, with both B2B and B2C channels contributing. Government support and telemedicine integration support market growth.

Buy Now & Unlock 360° Market Intelligence:
https://www.datamintelligence.com/buy-now-page?report=europe-digital-therapeutics-market

Request for 2 Days FREE Trial Access:
https://www.datamintelligence.com/reports-subscription?prasad

✅ Competitive Landscape
✅ Technology Roadmap Analysis
✅ Sustainability Impact Analysis
✅ KOL / Stakeholder Insights
✅ Consumer Behavior & Demand Analysis
✅ Import-Export Data Monitoring
✅ Live Market & Pricing Trends

Have a look at our Subscription Dashboard:
https://www.youtube.com/watch?v=x5oEiqEqTWg

Contact Us -
Company Name: DataM Intelligence
Contact Person: Sai Kiran
Email: Sai.k@datamintelligence.com
Phone: +1 877 441 4866
Website: https://www.datamintelligence.com

About Us -
DataM Intelligence is a Market Research and Consulting firm that provides end-to-end business solutions to organizations from Research to Consulting. We, at DataM Intelligence, leverage our top trademark trends, insights and developments to emancipate swift and astute solutions to clients like you. We encompass a multitude of syndicate reports and customized reports with a robust methodology.
Our research database features countless statistics and in-depth analyses across a wide range of 6300+ reports in 40+ domains creating business solutions for more than 200+ companies across 50+ countries; catering to the key business research needs that influence the growth trajectory of our vast clientele.

This release was published on openPR.